S. N. Vogel

发表

Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody

S. N. Vogel, E. A. Havell, S. Vogel, 1990, Infection and immunity.

Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes

E. N. Kaufman, M. Tate, S. Vogel, 1988, Infection and immunity.

Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection

S. Vogel, S. N. Vogel, D. Fertsch, 1987, Journal of virology.

Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii

A. Sher, G. Trinchieri, R. Gazzinelli, 1996, Infection and immunity.

Interferons with special emphasis on the immune system.

R. Friedman, S. Vogel, S. N. Vogel, 1983, Advances in immunology.

Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor

J. Abrams, S. N. Vogel, R. Neta, 1992, The Journal of experimental medicine.

Recombinant interferons increase macrophage Fc receptor capacity.

S. Vogel, S. N. Vogel, D. Fertsch, 1984, Journal of immunology.

In vivo modulation with anti-interleukin-1 (IL-1) receptor (p80) antibody 35F5 of the response to IL-1. The relationship of radioprotection, colony-stimulating factor, and IL-6.

S. N. Vogel, R. Neta, W. Benjamin, 1990, Blood.

Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal

S. N. Vogel, D. Fertsch, S. Vogel, 1984, Infection and immunity.

Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice.

R. Nordan, J. Sipe, S. N. Vogel, 1988, Lymphokine research.

Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia

S. N. Vogel, R. Neta, B. Henricson, 1991, Infection and immunity.

An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance

S. N. Vogel, R. Neta, B. Henricson, 1991, Infection and immunity.

Interferon-induced enhancement of macrophage Fc receptor expression: beta-interferon treatment of C3H/HeJ macrophages results in increased numbers and density of Fc receptors.

D. Rosenstreich, S. N. Vogel, K. English, 1983, Journal of immunology.

Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages

A. Sher, C. Manthey, S. N. Vogel, 1994, Infection and immunity.

Elimination of trace endotoxin protein from rough chemotype LPS

C. Manthey, S. N. Vogel, S. Vogel, 1994 .

Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction

C. Natanson, R. Danner, J. Spitzer, 1994 .

Phytohemagglutinin stimulation of enhanced immunoglobulin G production in mice inoculated with type III pneumococcal polysaccharide

S. N. Vogel, B. S. Roberson, S. Vogel, 1978, Infection and immunity.

Exogenous tumor necrosis factor alpha and interleukin-1 alpha increase resistance to Salmonella typhimurium: efficacy is influenced by the Ity and Lps loci

P. Morrissey, S. Vogel, S. N. Vogel, 1995, Infection and immunity.

Silica enhancement of murine endotoxin sensitivity

S. N. Vogel, K. English, A. O’Brien, 1982, Infection and immunity.